Carin Fradin Joins Sagent Advisors

SAN FRANCISCO, Feb. 24, 2011 /PRNewswire/ -- Sagent Advisors Inc. announced today that Carin Fradin has joined the firm as a Managing Director in the firm's healthcare group.  The addition of Ms. Fradin coincides with Sagent's acquisition earlier this month of the investment banking team from Montgomery Marshall Healthcare Partners ("MMHCP").  Ms. Fradin will continue her focus on the Medical Technology sector and be based in the firm's San Francisco office.

"We are thrilled to have a banker of Carin's exceptional caliber join our expanding healthcare team," said Hal Ritch, Sagent Advisors' Chief Executive Officer.  "As our recent additions of senior bankers demonstrate, advisors and clients are increasingly attracted to the independent investment banking model that we are building at Sagent."

Ms. Fradin joins a rapidly expanding healthcare practice at the firm, including recent hires, George Montgomery and Keith Marshall, Ph.D. from MMHCP, and former Bank of America Merrill Lynch healthcare banker, Shruthi Kinkead.  

"Since arriving at Sagent earlier this month, we have been impressed with the wealth of resources in the firm and the impact being part of Sagent has on our ability to build what is most important to us – our relationships with our clients," said George Montgomery, Managing Director in the firm's Life Sciences practice. "Adding a partner with Carin's expertise further expands the firm's healthcare efforts and enhances the quality and breadth of service we can offer our clients."

Ms. Fradin has over 10 years of investment banking experience in various sectors of the healthcare industry, working primarily with medical technology clients around the world.  She has devoted a large portion of her career to emerging technology companies in a wide variety of segments of the medical device market.  Prior to joining Sagent, Ms. Fradin was a Managing Director in the UBS Investment Bank Global Healthcare Group, where she started in 1998.  Since 2005, she was also responsible for developing UBS's medical device practice in Asia.  While at UBS, she led the first two U.S. initial public offerings for China-based healthcare companies, China Medical Technologies, Inc. and Mindray Medical International Limited.  

Ms. Fradin graduated cum laude from the University of Pennsylvania with a BA in both Mathematics and Psychology.

ABOUT SAGENT ADVISORS INC.

Sagent Advisors is an independent, privately-owned investment bank that provides financial advisory and capital raising solutions to clients in connection with mergers, acquisitions, restructurings and other strategic financial transactions. With over 70 investment bankers, the firm provides broad industry and product sector expertise to its clients through its offices in the U.S. in New York, Charlotte, Chicago and San Francisco, and globally through its alliance with Daiwa Securities Capital Markets in Asia and DC Advisory Partners in Europe.  Sagent Advisors offers a unique combination of powerful global relationship networks, strong industry and execution expertise, and senior attention on every client transaction.

SOURCE Sagent Advisors Inc.